{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:30:01Z","timestamp":1794072601934,"version":"4.8.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971580"],"award-info":[{"award-number":["81971580"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271951"],"award-info":[{"award-number":["82271951"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222167"],"award-info":[{"award-number":["7222167"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.urolonc.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T12:18:58Z","timestamp":1701173938000},"page":"23.e5-23.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus"],"prefix":"10.1016","volume":"42","author":[{"given":"Jian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0717-1748","authenticated-orcid":false,"given":"Haiyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2023.11.001_bib0001","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2022.12.001","article-title":"Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0003","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaccao.2022.07.011","article-title":"Prevalence, treatment, and prognosis of tumor thrombi in renal cell carcinoma","volume":"4","author":"Kaptein","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0004","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.eururo.2015.12.001","article-title":"Robot-assisted laparoscopic inferior vena cava thrombectomy: different sides require different techniques","volume":"69","author":"Wang","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12885-021-08508-x","article-title":"Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0006","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer (review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.06.110","article-title":"Ki67 is a graded rather than a binary marker of proliferation versus quiescence","volume":"24","author":"Miller","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.643065","article-title":"Review of prognostic expression markers for clear cell renal cell carcinoma","volume":"11","author":"Petitprez","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.urolonc.2023.11.001_bib0009","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bju.12263","article-title":"Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma","volume":"113","author":"Gayed","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/CM9.0000000000000109","article-title":"Automated quantification of Ki-67 index associates with pathologic grade of pulmonary neuroendocrine tumors","volume":"132","author":"Wang","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0011","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1038\/s41598-019-49139-4","article-title":"Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images","volume":"9","author":"Joseph","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0012","doi-asserted-by":"crossref","first-page":"44281","DOI":"10.1038\/srep44281","article-title":"Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis","volume":"7","author":"Xie","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.urolonc.2023.11.001_bib0013","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2019.01.011","article-title":"Ki-67 protein as a tumour proliferation marker","volume":"491","author":"Menon","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0014","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1158\/1078-0432.CCR-04-0488","article-title":"Using protein expressions to predict survival in clear cell renal carcinoma","volume":"10","author":"Kim","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0015","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/cncr.24263","article-title":"Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma","volume":"115","author":"Parker","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0016","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1158\/1078-0432.CCR-04-1776","article-title":"Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma","volume":"11","author":"Dudderidge","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0017","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1442-2042.2001.00379.x","article-title":"Growth fractions of human renal cell carcinoma defined by monoclonal antibody Ki-67. Predictive values for prognosis","volume":"8","author":"Yuba","year":"2001","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0018","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/CMAR.S141670","article-title":"Prognostic and clinicopathological value of Ki-67\/MIB-1 expression in renal cell carcinoma: a meta-analysis based on 4579 individuals","volume":"9","author":"Wang","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0019","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and male genital organs-part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0021","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2021.02.009","article-title":"Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma","volume":"154","author":"Li","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0022","first-page":"174","article-title":"The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans","volume":"21","author":"Adem","year":"2021","journal-title":"Bosn J Basic Med Sci"},{"issue":"8","key":"10.1016\/j.urolonc.2023.11.001_bib0023","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1002\/cam4.5693","article-title":"Prognostic analysis of three forms of Ki-67 in patients with breast cancer with non-pathological complete response before and after neoadjuvant systemic treatment","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0024","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12885-019-5324-y","article-title":"Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0025","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11255-022-03406-y","article-title":"Circulating tumor cells correlating with Ki-67 predicts the prognosis of bladder cancer patients","volume":"55","author":"Liu","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0026","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ctrv.2018.06.014","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to oncologic outcomes for renal cell carcinoma with tumor thrombus treated by radical nephrectomy with thrombectomy","volume":"69","author":"Gu","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0027","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mc.22300","article-title":"Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer","volume":"55","author":"Islam","year":"2016","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0028","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1464-410X.2008.08014.x","article-title":"Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma","volume":"103","author":"Capitanio","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0029","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.21037\/cdt.2017.09.16","article-title":"Tumor thrombus: incidence, imaging, prognosis and treatment","volume":"7","author":"Quencer","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00345-014-1276-7","article-title":"Clinical management of renal cell carcinoma with venous tumor thrombus","volume":"32","author":"Agochukwu","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.10.001","article-title":"Adjuvant therapy for locally advanced renal cell carcinoma: a meta-analysis and systematic review","volume":"36","author":"Bai","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0032","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.urolonc.2021.07.022","article-title":"Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysis","volume":"39","author":"Laukhtina","year":"2021","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/OTT.S393296","article-title":"Adjuvant therapy for high-risk localized renal cell carcinoma: current landscape and future direction","volume":"16","author":"Buller","year":"2023","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.urolonc.2023.11.001_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.6004\/jnccn.2022.0001","article-title":"Kidney cancer, version 3.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Motzer","year":"2022","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923003538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143923003538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:28:22Z","timestamp":1761042502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143923003538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1078143923003538"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.11.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Ki-67 proliferation index in prognosis prediction in patients with nonmetastatic clear cell renal cell carcinoma and tumor thrombus","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}